AAAAAA

   
Results: 1-14 |
Results: 14
Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications
Authors: Tabor, MP Brakenhoff, RH van Houten, VMM Kummer, JA Snel, MHJ Snijders, PJF Snow, GB Leemans, CR Braakhuis, BJM
Citation: Mp. Tabor et al., Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications, CLIN CANC R, 7(6), 2001, pp. 1523-1532
Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes
Authors: Klaassen, I Brakenhoff, RH Smeets, SJ Snow, GB Braakhuis, BJM
Citation: I. Klaassen et al., Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes, CLIN CANC R, 7(4), 2001, pp. 1017-1025
Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines
Authors: Klaassen, I Brakenhoff, RH Smeets, SJ Snow, GB Braakhuis, BJM
Citation: I. Klaassen et al., Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines, INT J CANC, 92(5), 2001, pp. 661-665
Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells
Authors: Klaassen, I Brakenhoff, RH Smeets, SJ Snow, GB Braakhuis, BJM
Citation: I. Klaassen et al., Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells, BR J CANC, 85(4), 2001, pp. 630-635
Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma
Authors: Cloos, J Leemans, CR van der Sterre, MLT Kuik, DJ Snow, GB Braakhuis, BJM
Citation: J. Cloos et al., Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma, CANC EPID B, 9(7), 2000, pp. 713-717
Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma
Authors: Aben, KKH Cloos, J Koper, NP Braakhuis, BJM Witjes, JA Kiemeney, LALM
Citation: Kkh. Aben et al., Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma, INT J CANC, 88(3), 2000, pp. 493-496
Inherited susceptibility to bleomycin-induced chromatid breaks in culturedperipheral blood lymphocytes
Authors: Cloos, J Nieuwenhuis, EJC Boomsma, DI Kuik, DJ van der Sterre, MLT Arwert, F Snow, GB Braakhuis, BJM
Citation: J. Cloos et al., Inherited susceptibility to bleomycin-induced chromatid breaks in culturedperipheral blood lymphocytes, J NAT CANC, 91(13), 1999, pp. 1125-1130
Plasma retinoid levels in head and neck cancer patients: a comparison withhealthy controls and the effect of retinyl palmitate treatment
Authors: Copper, MP Klaassen, I Teerlink, T Snow, GB Braakhuis, BJM
Citation: Mp. Copper et al., Plasma retinoid levels in head and neck cancer patients: a comparison withhealthy controls and the effect of retinyl palmitate treatment, ORAL ONCOL, 35(1), 1999, pp. 40-44
Mutagen sensitivity in common cutaneous malignant melanoma and dysplastic naevus syndrome
Authors: Cloos, J Willems, EM van Warmerdam, JMB Braakhuis, BJM Snow, GB Meijer, S
Citation: J. Cloos et al., Mutagen sensitivity in common cutaneous malignant melanoma and dysplastic naevus syndrome, MELANOMA RE, 9(3), 1999, pp. 292-296
The potential of platinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy
Authors: Welters, MJP Braakhuis, BJM Jacobs-Bergmans, AJ Kegel, A Baan, RA van der Vijgh, WJF Fichtinger-Schepman, AMJ
Citation: Mjp. Welters et al., The potential of platinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy, ANN ONCOL, 10(1), 1999, pp. 97-103
Considerations for in vitro retinoid experiments: importance of protein interaction
Authors: Klaassen, I Brakenhoff, RH Smeets, SJ Snow, GB Braakhuis, BJM
Citation: I. Klaassen et al., Considerations for in vitro retinoid experiments: importance of protein interaction, BBA-GEN SUB, 1427(2), 1999, pp. 265-275
Effect of cisplatin exposure on platinum accumulation and growth inhibition in human neoplastic and normal squamous epithelial cells of the mucosa ofthe upper-aerodigestive tract
Authors: Braakhuis, BJM Welters, MJP Cloos, J Pankras, JE Smeets, SJ Fichtinger-Schepman, AMJ
Citation: Bjm. Braakhuis et al., Effect of cisplatin exposure on platinum accumulation and growth inhibition in human neoplastic and normal squamous epithelial cells of the mucosa ofthe upper-aerodigestive tract, CANCER LETT, 138(1-2), 1999, pp. 217-220
A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects
Authors: Cloos, J Reid, CBA van der Sterre, MLT Tobi, H Leemans, CR Snow, GB Braakhuis, BJM
Citation: J. Cloos et al., A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects, MUTAGENESIS, 14(1), 1999, pp. 87-93
Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo
Authors: Welters, MJP Fichtinger-Schepman, AMJ Baan, RA Jacobs-Bergmans, AJ Kegel, A van der Vijgh, WJF Braakhuis, BJM
Citation: Mjp. Welters et al., Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo, BR J CANC, 79(1), 1999, pp. 82-88
Risultati: 1-14 |